📞 (586) 623-5616 ✉️ [email protected]
2026 hospice valuation multiples report with U.S. EBITDA benchmarks

Key Drivers of Hospice Valuation Multiples in 2026

A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.

Chart showing key drivers that impact hospice EBITDA multiples, including compliance risk, earnings quality, and referral concentration.

Hospice Multiples in the Current Market

Learn how hospice EBITDA multiples are set in today’s market—what drives the multiple, how compliance affects value, and how owners can prepare to maximize price.

Hospice M&A rebounds with strongest quarter since 2021, highlighting hospice valuation trends and buyer demand for quality agencies

Hospice M&A Rebounds: What the “Strongest Quarter Since 2021” Means for Hospice Owners Considering a Sale

Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.

Top questions to ask an advisor before getting a hospice valuation and preparing to sell

Top 10 Questions to Ask an Advisor Before Getting a Hospice Valuation

Getting a hospice valuation is more than a number — it shapes your exit timing, buyer confidence, and deal terms. Here are 10 questions every hospice owner should ask an advisor before starting the valuation process.

Professional Vallexa Advisors banner showcasing global healthcare M&A expertise with a blue networked globe symbolizing connection, trust, and growth.

Hospice Valuation amid Shutdowns & Policy Shifts: What Owners Need to Know

Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.

Digital illustration of healthcare professionals analyzing hospice valuation data and compliance metrics, representing Vallexa Advisors’ 2026 guide to hospice valuation under the HOPE Tool and Final Rule.

How the 2026 Final Rule and HOPE Tool Shape Hospice Valuation

The 2026 Final Rule and HOPE Tool are reshaping how hospice valuations are calculated. Learn how quality metrics, compliance, and data transparency affect your agency’s value — and how Vallexa Advisors helps owners navigate the changing market.

Illustration showing healthcare professionals and hospice valuation metrics, representing Vallexa Advisors’ expert guide on maximizing hospice agency value.

Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth

Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.

Vallexa Advisors illustration for selling a senior healthcare business, showing a facility silhouette, handshake and upward bar chart

Comprehensive Guide to Selling Senior Healthcare Businesses: Assisted Living, Hospice, Home Health & More

Thinking of selling your assisted living, RCFE, hospice, home health or skilled nursing business? Learn current valuation ranges, key drivers and steps to maximize value. Vallexa Advisors guides healthcare owners through a confidential, high‑value exit.

Vallexa Advisors image for how to sell a home health care business showing caregiver assisting senior with growth chart

How to Sell a Home Health Care Business: Your Roadmap to Maximum Value with Vallexa Advisors

If you’re ready to sell a home health care business, partner with Vallexa Advisors. We specialize in home health business valuation, appraisal and sale—from “sell my home health agency” to full transition. Maximize value. Minimize risk.

Vallexa Advisors hospice valuation 2025 blog graphic showing healthcare M&A expert explaining hospice business sale strategy

Hospice Valuation in 2025: Why Big Buyers Are Sitting Out & Why You Need Vallexa to Sell Your Hospice Business

Hospice valuation is under pressure, and big buyers are stepping back. If you’re ready to sell your hospice business, the right specialist matters. Vallexa Advisors guides you through hospice appraisal, steps to sell hospice, and captures maximum value with certainty.